focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Lower call; JD Sports suffers interim profit fall

Thu, 22nd Sep 2022 07:46

(Alliance News) - Stocks in London are set to open lower on Thursday, ahead of a major interest rate decision by the Bank of England and a day after the US Federal Reserve settled for another three-quarter-point rate hike.

The Federal Reserve "will keep at it" until inflation is well and truly tackled, Chair Jerome Powell said on Wednesday after a third successive 75 basis point rate hike by the central bank.

A third 75 basis point hike on-the-trot took the target range for the federal funds rate to 3.00% to 3.25%. The three-quarter point hike was largely what the market expected, though there had been some that believed the Fed would turn to a 1% lift.

On Thursday, the latest Bank of England will unveil its own interest rate decision at 1200 BST.

At the previous meeting, the BoE increased bank rate by half a percentage point to 1.75% from 1.25%. It was the largest rate rise since 1995.

In the US on Wednesday, Wall Street ended firmly in the red and the dollar was stronger following the US Fed decision.

In early UK corporate news on Thursday, sportswear retailer JD Sports announced a rise in interim revenue but a drop in profit, though it said the results were ahead of expectations.

Here is what you need to know ahead of the London market open:

----------

MARKETS

----------

FTSE 100: called down 0.9% at 7,173.60

----------

Hang Seng: down 1.9% at 18,098.41

Nikkei 225: closed down 0.6% at 27,153.83

Sydney market closed for holiday.

----------

DJIA: closed down 522.45 points, 1.7%, at 30,183.78

S&P 500: closed down 1.7% at 3,789.93

Nasdaq Composite: closed down 1.8% at 11,220.19

----------

EUR: down at USD0.9819 (USD0.9879)

GBP: down at USD1.1230 (USD1.1336)

USD: up at JPY145.25 (JPY144.13)

Gold: down at USD1,659.25 per ounce (USD1,667.36)

Oil (Brent): up at USD90.30 a barrel (USD89.80)

(changes since previous London equities close)

----------

ECONOMICS

----------

Thursday's key economic events still to come:

Australia National Holiday holiday. Financial markets closed.

16:00 CEST EU flash consumer confidence

12:00 BST UK BoE interest rate decision

08:30 EDT US unemployment claims

08:30 EDT US weekly export sales

10:00 EDT US leading indicators

11:00 EDT US Fed Kansas City survey

16:30 EDT US federal discount window borrowings

16:30 EDT US foreign central bank holdings

----------

EU foreign policy chief Josep Borrell has promised new sanctions targeting Russia following President Vladimir Putin's latest escalation in his war against Ukraine. "We decided to bring forward as soon as possible additional restrictive measures against Russia in coordination with partners," Borrell said late on Wednesday following a meeting of EU foreign ministers on the sidelines of the UN General Assembly in New York. The meeting was convened by Borrell after Putin ordered the partial mobilization of reservists in order to bolster his military's flagging efforts in Ukraine.

----------

Manufacturers in the UK have slashed their growth forecasts for next year amid "gathering storm clouds" for industry. Make UK said a survey of firms suggested growth in the sector of just 0.6% in 2023, down from 1.7% as recently as June. The manufacturers' organisation has cut its forecast for economic growth from 3.6% this year to 0.3% in 2023. Make UK called on the government to bring forward a "shock and awe" package of policy measures in its mini-budget on Friday in line with those seen during the worst points of the pandemic to help protect viable companies and avert significant job losses.

----------

BROKER RATING CHANGES

----------

Berenberg cuts Aveva Group to 'hold' from 'buy'

----------

JPMorgan reinitiates FirstGroup with 'overweight'

----------

RBC starts Ceres Power with 'sector perform'

----------

COMPANIES - FTSE 100

----------

Sportswear retailer JD Sports announced a rise in interim revenue but a drop in profit, which it said was due to the previous year experiencing a one-off benefit in the US from government stimulus. In the six months to July 30, revenue rose to GBP4.42 billion from GBP3.89 billion a year previous. Cost of sales ticked up to GBP2.28 billion from GBP2.00 billion. Pretax profit dropped to GBP298.3 million from GBP364.6 million. Chair Andrew Higginson says the results were at the "top end" of the company's expectations. JD Sports reinstated an interim dividend of 0.13 pence per share. It added that it expects its pretax profit for the year as a whole to be in line with the record performance for the year that ended this past January 29.

----------

Safety equipment maker Halma said its progress in the first half of its financial year to date has been in line with expectations, despite a challenging operational environment. It noted strong demand for products and services, with order intake "strongly" ahead of both revenue in the year to date and order intake for the same period last year. Halma left its revenue growth guidance for the full-year unchanged at "good single digit percentage organic constant currency revenue growth."

----------

Pharmaceutical firm AstraZeneca, along with American pharmaceutical firm Merck & Co, announced that Lynparza has been approved in China for the treatment of adults with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to first-line platinum-based chemotherapy in combination with bevacizumab, and whose cancer is associated with homologous recombination deficiency-positive status. The approval was based on a Paola-1 phase III trial which showed Lynparza plus bevacizumab demonstrated a substantial progression-free survival improvement versus bevacizumab alone for patients with HRD-positive advanced ovarian cancer.

----------

Telecommunications firm BT said that its workers, along with those at Openreach, are to stage fresh strikes in a long-running dispute over pay. The Communication Workers Union said its members will walk out on October 6, 10, 20 and 24. The action will include the tens of thousands of Openreach engineers and BT call centre workers who have walked out in previous months. The dispute centres on workers opposing the imposition by company management of an "incredibly low" flat-rate pay rise of GBP1,500 which the union said was a real-terms pay cut because of the soaring rate of inflation.

----------

COMPANIES - FTSE 250

----------

Gambling software firm Playtech reported a fall in pretax profit but a rise in revenue in the six months ended June 30. Revenue jumped to EUR792.3 million from EUR457.4 million, while pretax profit fell to EUR103.7 million from EUR278.1 million. The fall in profit was balmed on "EUR299.9 million of unrealised fair value gains on derivative financial assets recognised in the prior period." Chief Executive Mor Weizer said the performance was ahead of expectations and powered by Playtech's B2B business in the Americas and Europe. Weizer added that this "excellent" performance has continued into the second half of the year.

----------

Personal healthcare and consumer goods maker PZ Cussons posted a "resilient" performance in the year ended May 31, with dips in both revenue and profit amid a "challenging" market backdrop. In the year, revenue slipped by 1.7% to GBP592.8 million from GBP603.3 million. Pretax profit declined 8.7% to GBP65.3 million from GBP71.5 million. Cost of sales grew 11% year-on-year. PZ Cussons blamed the fall in profit on the reduction in revenue and a brand impairment. It increased its final dividend to 6.40 pence from 6.09 pence, however. The company also noted a "good" start to financial 2023.

----------

OTHER COMPANIES

----------

Veterinary service provider CVS Group posted a rise in annual profit and revenue as the company benefited from favourable and "resilient" market dynamics in the year. In the year ended June 30, revenue rose 8.6% to GBP554.2 million from GBP510.1 million, while pretax profit climbed 8.8% to GBP36.0 million from GBP33.1 million. CVS also increased its final dividend to 7.0 pence per share from 6.5p the prior year. In the first 10 weeks of its new financial year, the firm reported strong sales and like-for-like growth against the previous year. CVS added that trading was in line with market expectations.

----------

By Heather Rydings; heatherrydings@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
25 Apr 2024 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 06:30

Sanofi Q1 profit slips on generic competition, forex effects

April 25 (Reuters) - Sanofi's said on Thursday first-quarter operating income declined 14.7% as unfavourable currency effects and cheap competition to multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more
12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.